---
title: "Quantum BioPharma Partners with MZ Group to Boost Investor Relations"
date: "2025-02-11 21:11:01"
summary: "Maximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions. Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart PortfolioAn update from Quantum Biopharma (..."
categories:
  - "tipranks_announcements"
lang:
  - "en"
translations:
  - "en"
tags:
  - "tipranks_announcements"
menu: ""
thumbnail: "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1306769920-750x406.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

### Maximize Your Portfolio with Data Driven Insights:

* Leverage the power of [TipRanks' Smart Score](https://www.tipranks.com/screener/top-smart-score-stocks), a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
* Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with  [Your Smart Portfolio](https://www.tipranks.com/smart-portfolio/holdings)

An update from Quantum Biopharma ( [(TSE:QNTM)](https://www.tipranks.com/stocks/tse:qntm) ) is now available.

Quantum BioPharma has engaged MZ Group to enhance its investor relations and shareholder communications, aiming to increase visibility in the capital markets. This strategic move highlights Quantum BioPharma’s focus on developing solutions for brain disorders and alcohol misuse, with products like unbuzzd™ and rekvry™ addressing excessive alcohol consumption. The collaboration with MZ Group is expected to bolster Quantum Biopharma’s market presence and attract investment, given the substantial unmet needs in its targeted health areas.

**More about Quantum Biopharma**

Quantum BioPharma is a biopharmaceutical company focused on developing innovative assets and biotech solutions for neurodegenerative, metabolic, and alcohol misuse disorders. The company, through its subsidiary Lucid Psycheceuticals, is advancing its lead compound Lucid-MS, which targets myelin degradation in multiple sclerosis. Additionally, Quantum BioPharma has developed the unbuzzd™ product and retains a significant stake in Celly Nutrition, which handles its over-the-counter version.

**YTD Price Performance:** 200.25%

**Average Trading Volume:** 2,382,468

**Technical Sentiment Consensus Rating:** Buy

**Current Market Cap:** $22.43M

See more data about QNTM stock on [TipRanks’ Stock Analysis page](https://www.tipranks.com/stocks/tse:qntm/stock-analysis).

Trending Articles:
------------------

* [Elon Musk’s Brother and Tesla Director Kimbal Sells $28M Worth of Stock](https://www.tipranks.com/news/elon-musks-brother-and-tesla-director-kimbal-sells-28m-worth-of-stock)
* [APLT Lawsuit Alert! Class Action Against Applied Therapeutics, Inc.](https://www.tipranks.com/news/aplt-lawsuit-alert-class-action-against-applied-therapeutics-inc)
* [‘Bullish Confirmation Coming,’ Says Investor About Super Micro Computer Stock](https://www.tipranks.com/news/bullish-confirmation-coming-says-investor-about-super-micro-computer-stock)

[tipranks_announcements](https://www.tipranks.com/news/company-announcements/quantum-biopharma-partners-with-mz-group-to-boost-investor-relations)
